Literature DB >> 12389094

Identification of CD16-2, a novel mouse receptor homologous to CD16/Fc gamma RIII.

Ludmila V Mechetina1, Alexander M Najakshin, Boris Y Alabyev, Nikolai A Chikaev, Alexander V Taranin.   

Abstract

It is believed that mouse Fc gamma RIII arose by an evolutionarily recent recombination, which brought together the extracellular domains from Fc gamma RII with the transmembrane/cytoplasmic region from the ancestor Fc gamma RIII. Here, we report identification of a mouse gene encoding a transmembrane receptor that may be regarded as the true ortholog of nonrodent CD16/Fc gamma RIII. Designated CD16-2, the novel protein is highly similar to human Fc gamma RIIIA in the signal peptide (60% identical residues), and in the extracellular domains (65%). Although the similarity between the two proteins is less conspicuous in the transmembrane/cytoplasmic region (54%), it is higher than between human Fc gamma RIIIA and mouse Fc gamma RIII (44%). However, the conserved transmembrane motif LFAVDTGL shared by rodent and human Fc gamma RIII and Fc epsilon RI has two replacements in CD16-2. The CD16-2 gene is tightly linked to the Fc gamma RIII and Fc gamma RII genes and consists of five exons. Northern blot analysis revealed that CD16-2 is expressed in peripheral blood leukocytes, as well as in spleen, thymus, colon and intestine. RT-PCR showed prominent expression in macrophage cell line J774. Based on sequence comparisons, it is suggested that the modern repertoire of the mammalian low affinity Fc receptors has resulted from repetitive duplications and/or recombinations of three ancestral genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12389094     DOI: 10.1007/s00251-002-0486-0

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  15 in total

Review 1.  Activating and inhibitory FcgammaRs in autoimmune disorders.

Authors:  Falk Nimmerjahn
Journal:  Springer Semin Immunopathol       Date:  2006-10-01

2.  Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.

Authors:  Thomas F Tedder; Aris Baras; Yan Xiu
Journal:  Springer Semin Immunopathol       Date:  2006-11-08

3.  ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils.

Authors:  Yue Wang; Jianming Wu; Robert Newton; Nooshin S Bahaie; Chunmei Long; Bruce Walcheck
Journal:  Biochim Biophys Acta       Date:  2012-12-08

4.  Critical but overlapping role of FcgammaRIII and FcgammaRIV in activation of murine neutrophils by immobilized immune complexes.

Authors:  Zoltán Jakus; Tamás Németh; J Sjef Verbeek; Attila Mócsai
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

5.  FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation.

Authors:  David A Mancardi; Bruno Iannascoli; Sylviane Hoos; Patrick England; Marc Daëron; Pierre Bruhns
Journal:  J Clin Invest       Date:  2008-10-23       Impact factor: 14.808

6.  Fcgamma receptors are crucial for the expression of acquired resistance to virulent Salmonella enterica serovar Typhimurium in vivo but are not required for the induction of humoral or T-cell-mediated immunity.

Authors:  Nathalie Menager; Gemma Foster; Sanja Ugrinovic; Hazel Uppington; Sjef Verbeek; Pietro Mastroeni
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

7.  Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages.

Authors:  Efstathios G Stamatiades; Marie-Eve Tremblay; Mathieu Bohm; Lucile Crozet; Kanchan Bisht; Daniela Kao; Carolina Coelho; Xiying Fan; William T Yewdell; Anne Davidson; Peter S Heeger; Sandra Diebold; Falk Nimmerjahn; Frederic Geissmann
Journal:  Cell       Date:  2016-07-28       Impact factor: 41.582

8.  Species-specific evolution of the FcR family in endothermic vertebrates.

Authors:  Svetlana A Fayngerts; Alexander M Najakshin; Alexander V Taranin
Journal:  Immunogenetics       Date:  2007-03-14       Impact factor: 3.330

9.  Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice.

Authors:  Rens Braster; Marijn Bögels; Hreinn Benonisson; Manfred Wuhrer; Rosina Plomp; Arthur E H Bentlage; Rianne Korthouwer; Remco Visser; J Sjef Verbeek; Marjolein van Egmond; Gestur Vidarsson
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

10.  Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.

Authors:  Yasuhito Hamaguchi; Yan Xiu; Kazuhiro Komura; Falk Nimmerjahn; Thomas F Tedder
Journal:  J Exp Med       Date:  2006-03-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.